India’s Surya Pharma Shutters Two Units Citing Paucity Of Funds
This article was originally published in PharmAsia News
Executive Summary
Analysts blame mismanagement to the downfall of the Indian API firm, which has diversified into areas like healthcare retail, including a tie up with U.S. footwear company Crocs Inc.